SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Eli Lilly Agrees to Acquire Calytrix Bio in Deal Worth Up to $1.5 Billion

Eli Lilly agreed to buy privately held Calytrix Bio in a deal worth up to $1.5 billion.

LLY

Related stories